About Alzamend Neuro (ALZN)
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel products for the treatment of Alzheimer's disease (Alzheimer's), bipolar disorder (BD), major depressive disorder (MDD) and post-traumatic ... Read more
- USD1.21
- USD1.28
- USD1.20
- USD15.06
- 0.80%
- --
- 110.50k
- 181.67k
- 7M
- 1.06
- -86.50%
Stock News
2 hours ago
Amazon licenses Melania Trump documentary, as Jeff Bezos cozies up to president-elect
CNBC
3 hours ago
Elon Musk Nearly Sold Struggling Tesla To Google For $6 Billion – But When He 'No Longer Needed A Savior,' The Deal Was Called Off
Yahoo
4 hours ago
Big Tech Comes Of Age – These Three Big Tech Stocks Began Paying Shareholder Dividends For The First Time In 2024
Yahoo
4 hours ago
Stock market manages strong start to 2025. Watch these potential pitfalls.
MarketWatch
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
